AU5673794A
(en)
*
|
1992-11-19 |
1994-06-08 |
Matthew C. Biery |
Production of monoclonal recombinant antibodies without the use of hybridomas by (in vitro) spleen fragment culture combined with isothermal self-sustained sequence replication of rna
|
EP0682121B1
(en)
*
|
1993-12-01 |
2002-08-28 |
Toyo Boseki Kabushiki Kaisha |
Method of amplifying and detecting target nucleic acid sequence by using thermostable enzymes
|
US5705366A
(en)
*
|
1994-09-15 |
1998-01-06 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Coamplification of target nucleic acids using volume exclusion agent in reaction composition, test kit and test device useful therefor
|
JPH08131171A
(ja)
*
|
1994-11-11 |
1996-05-28 |
Asahi Chem Ind Co Ltd |
逆転写酵素の安定化組成物
|
US5763184A
(en)
|
1996-01-30 |
1998-06-09 |
Roche Molecular Systems, Inc. |
Nucleotide sequence variation in the ABO glycosyltransferase gene
|
WO2000000638A2
(en)
*
|
1998-06-26 |
2000-01-06 |
Akzo Nobel N.V. |
Tagging of rna amplicons generated by transcription-based amplification
|
JP2001029078A
(ja)
*
|
1999-07-16 |
2001-02-06 |
Shimadzu Corp |
Rna増幅法
|
EP1307469B1
(en)
|
2000-08-03 |
2008-01-23 |
Boehringer Mannheim Gmbh |
Nucleic acid binding compounds containing pyrazolo¬3,4-d pyrimidine analogues of purin-2,6-diamine and their uses
|
US6841349B2
(en)
|
2001-05-07 |
2005-01-11 |
Applera Corporation Applied Biosystems Group |
Methods for the reduction of stutter in microsatellite amplification
|
US6780588B2
(en)
*
|
2001-05-07 |
2004-08-24 |
Applera Corporation |
Methods for the reduction of stutter in microsatellite amplification
|
US9261460B2
(en)
|
2002-03-12 |
2016-02-16 |
Enzo Life Sciences, Inc. |
Real-time nucleic acid detection processes and compositions
|
US9777312B2
(en)
|
2001-06-30 |
2017-10-03 |
Enzo Life Sciences, Inc. |
Dual polarity analysis of nucleic acids
|
US20040161741A1
(en)
|
2001-06-30 |
2004-08-19 |
Elazar Rabani |
Novel compositions and processes for analyte detection, quantification and amplification
|
DE60316660T3
(de)
|
2002-01-08 |
2016-01-28 |
Roche Diagnostics Gmbh |
Verwendung eines silikamaterials bei der amplifikation
|
US7122314B2
(en)
|
2002-01-30 |
2006-10-17 |
Id Biomedical Corporation |
Methods for detecting vancomycin-resistant microorganisms and compositions therefor
|
US9353405B2
(en)
|
2002-03-12 |
2016-05-31 |
Enzo Life Sciences, Inc. |
Optimized real time nucleic acid detection processes
|
DE10240868A1
(de)
*
|
2002-09-04 |
2004-03-18 |
Artus Gesellschaft für molekularbiologische Diagnostik und Entwicklung mbH |
Verbesserte Verfahren zur Synthese von Nukleinsäuren
|
EP1590362B8
(en)
|
2003-01-29 |
2015-06-03 |
Epigenomics AG |
Improved method for bisulfite treatment
|
JP2004357502A
(ja)
*
|
2003-05-30 |
2004-12-24 |
Olympus Corp |
核酸分子を使用した情報処理方法
|
JPWO2006006722A1
(ja)
|
2004-07-13 |
2008-05-01 |
武田薬品工業株式会社 |
細胞機能の調節方法
|
EP1632578A1
(en)
|
2004-09-03 |
2006-03-08 |
Roche Diagnostics GmbH |
DNA decontamination method
|
GB0701253D0
(en)
|
2007-01-23 |
2007-02-28 |
Diagnostics For The Real World |
Nucleic acid amplification and testing
|
US8420315B2
(en)
|
2007-08-06 |
2013-04-16 |
Orion Genomics Llc |
Single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the IGF2 gene
|
CA2639416C
(en)
|
2007-09-11 |
2019-12-31 |
F. Hoffmann-La Roche Ag |
Diagnostic test for susceptibility to b-raf kinase inhibitors
|
WO2009059317A2
(en)
|
2007-11-01 |
2009-05-07 |
University Of Iowa Research Foundation |
Predicting amd with snps within or near c2, factor b, plekha1, htra1, prelp, or loc387715
|
AU2010213727A1
(en)
|
2009-02-11 |
2011-09-29 |
Orion Genomics Llc |
Combinations of polymorphisms for determining allele-specific expression of IGF2
|
WO2011128096A1
(en)
|
2010-04-16 |
2011-10-20 |
Roche Diagnostics Gmbh |
Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
|
US20130143214A1
(en)
|
2010-06-04 |
2013-06-06 |
Chronix Biomedical |
Prostate cancer associated circulating nucleic acid biomarkers
|
WO2012040619A2
(en)
|
2010-09-24 |
2012-03-29 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for prognosing and/or detecting age-related macular degeneration
|
WO2012054727A1
(en)
|
2010-10-22 |
2012-04-26 |
Bio-Rad Laboratories, Inc. |
Reverse transcriptase mixtures with improved storage stability
|
WO2013030167A1
(en)
|
2011-08-31 |
2013-03-07 |
F. Hoffmann-La Roche Ag |
Responsiveness to angiogenesis inhibitors
|
AU2012300986A1
(en)
|
2011-08-31 |
2014-02-13 |
F. Hoffmann-La Roche Ag |
Method for predicting risk of hypertension associated with anti-angiogenesis therapy
|
CN103930111A
(zh)
|
2011-09-19 |
2014-07-16 |
霍夫曼-拉罗奇有限公司 |
包含c-met拮抗剂和b-raf拮抗剂的组合治疗
|
ES2729554T3
(es)
|
2011-10-21 |
2019-11-04 |
Chronix Biomedical |
Biomarcadores de ácidos nucleicos en circulación asociados al cáncer colorrectal
|
CA2854568A1
(en)
|
2011-11-23 |
2013-05-30 |
Life Sciences Research Partners Vzw |
Responsiveness to angiogenesis inhibitors
|
US9115394B2
(en)
|
2011-12-22 |
2015-08-25 |
Roche Molecular Systems, Inc. |
Methods and reagents for reducing non-specific amplification
|
HRP20190209T4
(hr)
|
2013-05-29 |
2023-09-15 |
Chronix Biomedical |
Detekcija i kvantifikacija acelularne dnk darivatelja u krvotoku primatelja presađivanja organa
|
SG10201808565QA
(en)
|
2014-03-31 |
2018-11-29 |
Debiopharm Int Sa |
Fgfr fusions
|
WO2016077366A1
(en)
|
2014-11-10 |
2016-05-19 |
Genentec, Inc. |
Therapeutic and diagnostic methods for il-33-mediated disorders
|
JP6966681B2
(ja)
|
2015-04-24 |
2021-11-17 |
アティラ バイオシステムズ インコーポレイテッドAtila Biosystems Incorporated |
限られたヌクレオチド組成を有するプライマーを用いた増幅
|
EP3995589A1
(en)
|
2015-08-17 |
2022-05-11 |
Kura Oncology, Inc. |
Methods of treating cancer patients with farnesyl transferase inhibitors
|
WO2017184968A1
(en)
|
2016-04-22 |
2017-10-26 |
Kura Oncology, Inc. |
Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
|
CA3042747A1
(en)
|
2016-11-03 |
2018-05-11 |
Kura Oncology, Inc. |
Methods of treating cancer patients with farnesyltransferase inhibitors
|
US10137121B2
(en)
|
2017-02-21 |
2018-11-27 |
Kura Oncology, Inc. |
Methods of treating cancer with farnesyltransferase inhibitors
|
CN109475550A
(zh)
|
2017-02-21 |
2019-03-15 |
库拉肿瘤学公司 |
使用法尼基转移酶抑制剂治疗癌症的方法
|
US10806730B2
(en)
|
2017-08-07 |
2020-10-20 |
Kura Oncology, Inc. |
Methods of treating cancer with farnesyltransferase inhibitors
|
WO2019032489A1
(en)
|
2017-08-07 |
2019-02-14 |
Kura Oncology, Inc. |
METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS
|
CA3226165A1
(en)
|
2018-02-09 |
2019-08-15 |
Genentech, Inc. |
Therapeutic and diagnostic methods for mast cell-mediated inflammatory diseases
|
EP3873469A2
(en)
|
2018-11-01 |
2021-09-08 |
Kura Oncology, Inc. |
Methods of treating cancer with farnesyltransferase inhibitors
|
US20220142983A1
(en)
|
2019-03-01 |
2022-05-12 |
Kura Oncology, Inc. |
Methods of treating cancer with farnesyltransferase inhibitors
|
AU2020254492A1
(en)
|
2019-03-29 |
2021-11-11 |
Kura Oncology, Inc. |
Methods of treating Squamous Cell Carcinomas with farnesyltransferase inhibitors
|
TW202102218A
(zh)
|
2019-04-01 |
2021-01-16 |
美商庫拉腫瘤技術股份有限公司 |
以法呢基(farnesyl)轉移酶抑制劑治療癌症的方法
|
US20220305001A1
(en)
|
2019-05-02 |
2022-09-29 |
Kura Oncology, Inc. |
Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors
|
JP2023516497A
(ja)
|
2020-03-13 |
2023-04-19 |
メドイミューン・リミテッド |
Il33にリスクアレルを有する対象を治療するための治療方法
|
WO2024015331A1
(en)
|
2022-07-12 |
2024-01-18 |
Genentech, Inc. |
Therapeutic and diagnostic methods for multiple sclerosis
|